Last reviewed · How we verify

NCT06248970

The Effect of Intermittent Oro-esophageal Tube Feeding on Severe Traumatic Brain Injury Patients With Tracheostomy

Terminated NA Last updated 7 March 2024
What this trial tests

NA trial testing Rehabilitation therapy in Traumatic Brain Injury in 104 participants. Terminated before completion.

Timeline
1 June 2022
Primary endpoint
13 May 2023
15 June 2023

Quick facts

Lead sponsorZeng Changhao
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment104
Start date1 June 2022
Primary completion13 May 2023
Estimated completion15 June 2023
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Zeng Changhao — full company profile →

Who can join

18 and older, any sex, with Traumatic Brain Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This was a multicenter randomized controlled study of 98 severe Traumatic Brain Injury patients with tracheostomy. Patients enrolled were divided randomly into the observation group with Intermittent Oro-esophageal Tube Feeding (n=50) or the control group with Nasogastric tube feeding (n=48) for enteral nutrition support, respectively. Nutritional status, complications, decannulation of tracheostomy tubes and level of consciousness on day 1 and day 28 were recorded and compared.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Rehabilitation therapy

Trials testing the same drug.

Other recruiting trials for Traumatic Brain Injury

Currently open trials in the same condition.

Other Zeng Changhao trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06248970.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing